Skip to content

Biodesix, Inc. BDSX Total Revenue

Total Revenue at other companies

NeoGenomics logo
NeoGenomicsNEO
$186.67M+11.1%
Veracyte logo
VeracyteVCYT
$139.07M+21.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$70.87M+35.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$15.47M-24.9%
Guardant Health logo
Guardant HealthGH
$301.67M+48.3%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$348.12M+36.1%

Segments

By product

See full
Diagnostic Tests$22.29M+36.6%
Development Services$3.26M+98.8%

Other financials

Income statement

See full
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%
P/S2.4×+1.9×

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s total revenue?
Biodesix, Inc. (BDSX) reported total revenue of $25.56M in Q1 2026.
How has Biodesix, Inc.'s total revenue changed year-over-year?
Biodesix, Inc.'s total revenue increased by 42.3% year-over-year, from $17.96M to $25.56M.
What is the long-term trend for Biodesix, Inc.'s total revenue?
Over 4 years (2021 to 2025), Biodesix, Inc.'s total revenue has grown at a 12.9% compound annual growth rate (CAGR), from $54.51M to $88.5M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.